Neutrophil-to-lymphocyte ratio evolution is an independent predictor of early progression of second-line nivolumab-treated patients with advanced non-small-cell lung cancers

द्वारा Dusselier, Matthieu, Deluche, Elise, Delacourt, Nellie, Ballouhey, Julia, Egenod, Thomas, Melloni, Boris, Vergnenègre, Charlotte, Veillon, Rémi, Vergnenègre, Alain
में प्रकाशित PLoS One (2019)

Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study

द्वारा Duruisseaux, Michaël, Besse, Benjamin, Cadranel, Jacques, Pérol, Maurice, Mennecier, Bertrand, Bigay-Game, Laurence, Descourt, Renaud, Dansin, Eric, Audigier-Valette, Clarisse, Moreau, Lionel, Hureaux, José, Veillon, Remi, Otto, Josiane, Madroszyk-Flandin, Anne, Cortot, Alexis, Guichard, François, Boudou-Rouquette, Pascaline, Langlais, Alexandra, Missy, Pascale, Morin, Franck, Moro-Sibilot, Denis
में प्रकाशित Oncotarget (2017)

Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

द्वारा Ferrara, Roberto, Mezquita, Laura, Texier, Matthieu, Lahmar, Jihene, Audigier-Valette, Clarisse, Tessonnier, Laurent, Mazieres, Julien, Zalcman, Gerard, Brosseau, Solenn, Le Moulec, Sylvestre, Leroy, Laura, Duchemann, Boris, Lefebvre, Corentin, Veillon, Remi, Westeel, Virginie, Koscielny, Serge, Champiat, Stephane, Ferté, Charles, Planchard, David, Remon, Jordi, Boucher, Marie-Eve, Gazzah, Anas, Adam, Julien, Bria, Emilio, Tortora, Giampaolo, Soria, Jean-Charles, Besse, Benjamin, Caramella, Caroline
में प्रकाशित JAMA Oncol (2018)